Cargando…
Should we allocate more COVID-19 vaccine doses to non-vaccinated individuals?
Following the approval by the FDA of two COVID-19 vaccines, which are administered in two doses three to four weeks apart, we simulate the effects of various vaccine distribution policies on the cumulative number of infections and deaths in the United States in the presence of shocks to the supply o...
Autores principales: | Ben Chaouch, Zied, Lo, Andrew W., Wong, Chi Heem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022372/ https://www.ncbi.nlm.nih.gov/pubmed/36962342 http://dx.doi.org/10.1371/journal.pgph.0000498 |
Ejemplares similares
-
A cost/benefit analysis of clinical trial designs for COVID-19 vaccine candidates
por: Berry, Donald A., et al.
Publicado: (2020) -
Optimizing vaccine allocation for COVID-19 vaccines: potential role of single-dose vaccination.
por: Matrajt, Laura, et al.
Publicado: (2021) -
Corruption should be taken into account when considering COVID-19 vaccine allocation
por: Spreco, Armin, et al.
Publicado: (2022) -
Should we stop methotrexate or not for vaccination?
por: Durez, Patrick, et al.
Publicado: (2023) -
Examining Provincial HPV Vaccination Schemes in Canada: Should We Standardise the Grade of Vaccination or the Number of Doses?
por: Rogers, Carley, et al.
Publicado: (2015)